PATENT CLAIM ANALYSIS

Application Number: 15950949
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "239500"]

Abstract:
The present invention provides methods for reducing loss of muscle strength, muscle mass, or Type I muscle fibers in an immobilized limb by administering (E)-[4-[3-(4-Fluorophenyl)-3-[4-[3-(morpholin-4-yl)propynyl]phenyl]allyloxy]-2-methyl-phenoxy]acetic acid or a pharmaceutically acceptable salt thereof.

Claim (Index 15):
A method of treating muscle atrophy in a subject comprising administering to the subject in need thereof a small molecule PPAR\u03b4 agonist, wherein the PPAR\u03b4 agonist:\n has a molecular weight of less than 1000 g/mol; \n an EC50 value of less than 500 nM as determined by a PPAR\u03b4 transient transactivation assay; and \n at least a 10 fold potency for activation of PPAR\u03b4 relative to either or both of PPAR\u03b1 and PPAR\u03b3.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 91.0
- Lexical Diversity: 1.34783
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14478594', '15286661', '12810123', '14016442', '15897796']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7474332040948065
- 35 USC 102 Novelty (BERT): 0.5808120625704496
- Combined Prediction Score: 0.7307710899423708
- Mean Citation Score: 360.081022
- Max Citation Score: 534.8824
- Similarity Product: 377.669871052742

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test